FDA continues finding products marketed as dietary supplements but containing the botanical acacia rigidula nearly a year after the agency identified the ingredient as the synthetic stimulant BMPEA.
Warning letters to six firms published March 15, like others FDA has submitted since April 2015, explain that acacia rigidula needs approval through a new dietary ingredient notification but is unlikely to be determined as safe, enforcement that the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?